Cargando…

Restoration of correct splicing in IVSI-110 mutation of β-globin gene with antisense oligonucleotides: implications and applications in functional assay development

OBJECTIVE(S): The use of antisense oligonucleotides (AOs) to restore normal splicing by blocking the recognition of aberrant splice sites by the spliceosome represents an innovative means of potentially controlling certain inherited disorders affected by aberrant splicing. Selection of the appropria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derakhshan, Sima Mansoori, Khaniani, Mahmoud Shekari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569442/ https://www.ncbi.nlm.nih.gov/pubmed/28868125 http://dx.doi.org/10.22038/IJBMS.2017.8840

Ejemplares similares

A novel missense variant in ESRRB gene causing autosomal recessive non-syndromic hearing loss: in silico analysis of a case
por: Ghasemnejad, Tohid, et al.
Publicado: (2022)

Minor role of BRCA2 mutation (Exon2 and Exon11) in patients with early-onset breast cancer amongst Iranian Azeri-Turkish women
por: Karimian Fathi, Nahid, et al.
Publicado: (2014)

Evaluation of a newly discovered breast cancer susceptibility locus at 6q25.1 in Iranian Azari-Turkish women
por: Garehdaghchi, Ziba, et al.
Publicado: (2016)

Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBB(IVSI−110 (G > A)) β-Thalassemia
por: Patsali, Petros, et al.
Publicado: (2020)

The Association between Human Leukocyte Antigen Class II DR3–DQ2 Haplotype and Type 1 Diabetes in Children of the East Azerbaijan State of Iran
por: Mansoori Derakhshan, Sima, et al.
Publicado: (2015)

Association study of IL2RA and CTLA4 Gene Variants with Type I Diabetes Mellitus in children in the northwest of Iran
por: Ranjouri, Mohammad Reza, et al.
Publicado: (2016)

Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β-Globin Gene with the IVSI-6 Thalassemia Mutation
por: Breveglieri, Giulia, et al.
Publicado: (2015)

Differential Expression Pattern of Epithelial Mesenchymal Transition Gens: AXL, GAS6, Claudin-1, and Cofilin-1, in Different Stages of Epithelial Ovarian Cancer
por: HASSANI, Elham, et al.
Publicado: (2019)

Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016)

Restoration of the Normal Splicing Pattern of the PLP1 Gene by Means of an Antisense Oligonucleotide Directed against an Exonic Mutation
por: Regis, Stefano, et al.
Publicado: (2013)

Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides
por: Aung-Htut, May T., et al.
Publicado: (2019)

A Sensitive Assay System To Test Antisense Oligonucleotides for Splice Suppression Therapy in the Mouse Liver
por: Gallego-Villar, Lorena, et al.
Publicado: (2014)

Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1
por: Bonifert, Tobias, et al.
Publicado: (2016)

Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
por: Wang, Zhenxun, et al.
Publicado: (2012)

Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides
por: Scharner, Juergen, et al.
Publicado: (2020)

Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
por: Ham, Kristin A., et al.
Publicado: (2021)

Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice
por: Sinha, Rahul, et al.
Publicado: (2018)

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
por: Lim, Kian Huat, et al.
Publicado: (2020)

Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides
por: Aung-Htut, May T., et al.
Publicado: (2019)

Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
por: Raguraman, Prithi, et al.
Publicado: (2021)

Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
por: Fragall, Clayton T, et al.
Publicado: (2011)

The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides
por: Ming, Xin, et al.
Publicado: (2013)

Inhibition of the expression of oncogene SRSF3 by blocking an exonic splicing suppressor with antisense oligonucleotides
por: Guo, Jihua, et al.
Publicado: (2018)

Optimization of Bifunctional Antisense Oligonucleotides for Regulation of Mutually Exclusive Alternative Splicing of PKM Gene
por: Bartyś, Natalia, et al.
Publicado: (2022)

Targeting novel human transient receptor potential ankyrin 1 splice variation with splice-switching antisense oligonucleotides
por: Huang, Hua, et al.
Publicado: (2021)

Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018)

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)

Antisense Oligonucleotides and RNA Interference
por: Kher, Gitanjali, et al.
Publicado: (2011)

Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease
por: Aung-Htut, May Thandar, et al.
Publicado: (2020)

The Effect of Xmn -1 Polymorphism and Coinheritance of Alpha Mutations on Age at First Blood Transfusion in Iranian Patients with Homozygote IVSI-5 Mutation
por: Hashemieh, Mozhgan, et al.
Publicado: (2022)

Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
por: Hinrich, Anthony J, et al.
Publicado: (2016)

Hybrid splicing minigene and antisense oligonucleotides as efficient tools to determine functional protein/RNA interactions
por: Cywoniuk, Piotr, et al.
Publicado: (2017)

Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis
por: Michaels, Wren E., et al.
Publicado: (2022)

Opportunities and challenges for antisense oligonucleotide therapies
por: Kuijper, Elsa C., et al.
Publicado: (2020)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
por: Jani, Saumya, et al.
Publicado: (2021)

Drug Discovery Perspectives of Antisense Oligonucleotides
por: Kim, Yeonjoon
Publicado: (2023)

In-silico study of antisense oligonucleotide antibiotics
por: Chen, Erica S., et al.
Publicado: (2023)

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849 + 10 kb C-to-T splicing mutation
por: Oren, Yifat S., et al.
Publicado: (2021)

LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts
por: Touznik, Aleksander, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ejv3iqcsk64doqud2pq4fi4ijd